Shuai Li | Biology and Life Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Shuai Li
Regeneron, United States
Shuai Li
Affiliation Regeneron
Country United States
Scopus ID 60597499200
Documents 6
Citations 221
h-index 4
Subject Area Biology and Life Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-1537-3956

The Innovative Research Award recognizes the scholarly and scientific contributions of Shuai Li, a researcher associated with Regeneron and previously affiliated with Duke University. Li has contributed to interdisciplinary research spanning synthetic biology, metabolic engineering, supramolecular chemistry, and automated bioprocess technologies. The research portfolio demonstrates a combination of experimental innovation, engineering methodology, and translational biological applications within the broader field of biology and life sciences.[1]

Abstract

Shuai Li has developed a multidisciplinary academic profile integrating biological engineering, synthetic biology, supramolecular chemistry, and automation systems for laboratory applications. Published works include contributions to metabolic engineering in Escherichia coli, chiral molecular assemblies, CRISPR-associated biological systems, and open-source laboratory automation. The body of work reflects ongoing efforts to optimize biological production systems, enhance molecular recognition strategies, and improve accessibility to bioprocess instrumentation.[2][3]

Keywords

Synthetic Biology; Metabolic Engineering; Bioprocess Automation; Supramolecular Chemistry; CRISPR Systems; NADPH Flux; Chiroptical Switches; Biological Engineering; Automated Sampling Systems; Life Sciences Research.

Introduction

Contemporary life sciences research increasingly depends upon interdisciplinary approaches that integrate chemistry, engineering, automation, and computationally informed biological experimentation. Shuai Li’s scholarly contributions reflect this evolving research landscape through work involving engineered microbial systems, supramolecular interfaces, and laboratory automation platforms.[4]

Li completed academic training at Shandong University and the Institute of Chemistry of the Chinese Academy of Sciences before continuing research activities at Duke University. These educational and research experiences contributed to a broad methodological background that spans chemical sciences and biotechnology-oriented engineering disciplines.[1]

Research Profile

The Scopus author profile associated with Shuai Li reports 221 citations across multiple indexed documents and an h-index of 4, indicating measurable academic engagement and scholarly visibility within biotechnology and chemistry-related research communities.[1]

Research topics explored by Li include metabolic pathway optimization, enzyme regulation, supramolecular assembly, CRISPR/Cas systems, and automated sampling technologies for bioreactors. Publications demonstrate collaborations across academic laboratories and interdisciplinary scientific environments.[5]

  • Research specialization in synthetic biology and metabolic engineering.
  • Contributions to supramolecular and chiral chemistry methodologies.
  • Development of low-cost automated laboratory technologies.

Research Contributions

Among Li’s notable contributions is the development of the BioSamplr, an open-source automated sampling system designed for bioreactors. The platform aimed to provide a lower-cost alternative for laboratory sampling automation, thereby increasing accessibility for smaller research laboratories and educational institutions.[2]

Li also contributed to research focused on improving NADPH flux and xylitol biosynthesis in engineered E. coli systems through dynamic regulatory control strategies. This work addressed feedback regulation mechanisms and metabolic optimization relevant to industrial biotechnology applications.[3]

Additional studies investigated CRISPR-associated endonuclease complexes and their effects on self-targeting spacer stability. These findings contributed to understanding microbial genome regulation and CRISPR system functionality.[6]

In the field of supramolecular chemistry, Li co-authored studies examining chiroptical switches, chiral metallogels, and self-assembled polydiacetylene systems for enantioselective recognition. These works demonstrated applications of molecular self-assembly and chirality transfer in advanced chemical systems.[7][8]

Publications

  1. BioSamplr: An open source, low cost automated sampling system for bioreactors — HardwareX (2021).
  2. Dynamic control over feedback regulatory mechanisms improves NADPH flux and xylitol biosynthesis in engineered E. coli — Metabolic Engineering (2021).
  3. Escherichia coli Cas1/2 Endonuclease Complex Modifies Self-Targeting CRISPR/Cascade Spacers Reducing Silencing Guide Stability — ACS Synthetic Biology (2020).
  4. Supramolecular chiroptical switches — Chemical Society Reviews (2020).
  5. Self-Assembled Polydiacetylene Vesicle and Helix with Chiral Interface for Visualized Enantioselective Recognition of Sulfinamide — ACS Applied Materials & Interfaces (2017).

Research Impact

The academic impact of Li’s work is reflected through citations, interdisciplinary collaborations, and publication in peer-reviewed journals covering biotechnology, synthetic biology, materials science, and supramolecular chemistry. Research outputs have relevance for both academic investigation and industrial biotechnology applications.[3][7]

The integration of engineering principles with biological systems research has contributed to emerging methodologies in automated experimentation and metabolic pathway optimization. Such interdisciplinary work supports broader scientific efforts aimed at improving efficiency, reproducibility, and accessibility in laboratory research environments.[2]

Award Suitability

Shuai Li’s multidisciplinary research background aligns with the objectives of the Global Innovation Technologist Awards, which recognize scientific and technological advancements with measurable academic and practical significance. Contributions spanning metabolic engineering, CRISPR research, supramolecular chemistry, and open-source automation technologies demonstrate consistent engagement with innovation-oriented scientific inquiry.[1]

The combination of peer-reviewed publications, measurable citation performance, and interdisciplinary technical expertise supports recognition within the field of biology and life sciences. Li’s work illustrates the integration of engineering design principles with biological and chemical sciences to address contemporary research challenges.[4]

Conclusion

The scholarly profile of Shuai Li reflects interdisciplinary scientific engagement across synthetic biology, supramolecular chemistry, and laboratory engineering technologies. Through publications in recognized journals and contributions to biological automation systems, Li has participated in research initiatives with relevance to modern biotechnology and life sciences. The body of work demonstrates methodological diversity, collaborative scientific activity, and continuing participation in innovation-oriented academic research.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Shuai Li, Author ID 60597499200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60597499200
  2. Li, S. et al. (2021). BioSamplr: An open source, low cost automated sampling system for bioreactors. HardwareX.
    https://doi.org/10.1016/j.ohx.2021.e00177
  3. Li, S. et al. (2021). Dynamic control over feedback regulatory mechanisms improves NADPH flux and xylitol biosynthesis in engineered E. coli. Metabolic Engineering.
    https://doi.org/10.1016/j.ymben.2021.01.005
  4. ORCID. (n.d.). Shuai Li ORCID profile and educational background.
    https://orcid.org/0000-0002-1537-3956
  5. Crossref Metadata Search. (n.d.). Publication metadata associated with Shuai Li.
  6. Li, S. et al. (2020). Escherichia coli Cas1/2 Endonuclease Complex Modifies Self-Targeting CRISPR/Cascade Spacers Reducing Silencing Guide Stability. ACS Synthetic Biology.
    https://doi.org/10.1021/acssynbio.0c00398
  7. Li, S. et al. (2020). Supramolecular chiroptical switches. Chemical Society Reviews.
    https://doi.org/10.1039/d0cs00191k
  8. Li, S. et al. (2017). Alanine-Based Chiral Metallogels via Supramolecular Coordination Complex Platforms: Metallogelation Induced Chirality Transfer. Journal of the American Chemical Society.
    https://doi.org/10.1021/jacs.7b10769

Kabore Kayaba | Biochemistry | Young Researcher Award

Published on by Innovation Technologist

Mr. Kabore Kayaba | Biochemistry | Young Researcher Award

Joseph KI Zerbo University of Ouagadougou | Burkina Faso

Mr. Kabore Kayaba is a food biochemist and agrotechnology researcher specializing in phytochemistry, functional foods, and bioactive compounds from indigenous African plants. His research integrates biochemical engineering, antioxidant science, and antimicrobial screening to develop nutritionally optimized and health-promoting food products from local resources. He has contributed to peer-reviewed journals on phenolic profiling, antioxidant capacity, and antimicrobial activity of plant extracts, notably Uvaria chamae, a traditional food plant from Burkina Faso. His work also extends to formulation and quality characterization of energy-dense foods for high-performance nutrition. Mr. Kabore Kayaba’s research emphasizes food security, value addition, and evidence-based utilization of underexploited botanical resources in Africa.

View ORCID Profile

Featured Publications

Supriyo Chakraborty | Biotechnology | Research Excellence Award

Published on by Innovation Technologist

Dr. Supriyo Chakraborty | Biotechnology | Research Excellence Award

Professor at Assam University | India

Dr. Supriyo Chakraborty is a distinguished biotechnology researcher and academic leader whose work spans plant genetics, molecular biology, bioinformatics, and population genetics. Renowned for his impactful contributions, he has authored a substantial body of research, reflected in 4911 citations (3972 since 2020), an h-index of 29 (24 since 2020), and an i10-index of 80 (54 since 2020). His research advances codon usage bias analysis, gene expression prediction, RNA virus genomics, and computational tools for genetic and peptide property analysis. He has developed multiple awarded software innovations that enhance genomic interpretation and statistical genetics, widely used across plant, animal, and microbial systems. His notable work includes microRNA-based viral gene silencing models, codon usage and RNA editing studies in bat-borne viruses, and gene regulation mechanisms in neurobiological conditions. His contributions to QTL mapping in rice, maize, and Drosophila have supported crop improvement and advanced quantitative genetics. He has also generated important insights into human population genetics through studies on ABO and Rh gene frequencies and genetic distance estimation. As a professor of biotechnology, he has mentored numerous doctoral scholars and strengthened research and teaching in genetics, molecular biology, and plant biotechnology. His scholarly books, book chapters, popular articles, and extensive participation in national and international scientific programs reflect his commitment to advancing scientific knowledge. Dr. Chakraborty’s multifaceted research portfolio and lasting contributions place him among the leading figures in contemporary biotechnology and genetic research.

Profile: Google Scholar

Featured Publications

Malakar, A. K., Choudhury, D., Halder, B., Paul, P., Uddin, A., & Chakraborty, S. (2019). A review on coronary artery disease, its risk factors, and therapeutics. Journal of Cellular Physiology, 234(10), 16812–16823.

Paul, P., Chakraborty, A., Sarkar, D., Langthasa, M., Rahman, M., Bari, M., & Chakraborty, S. (2018). Interplay between miRNAs and human diseases. Journal of Cellular Physiology, 233(3), 2007–2018.

Khawbung, J. L., Nath, D., & Chakraborty, S. (2021). Drug resistant Tuberculosis: A review. Comparative Immunology, Microbiology and Infectious Diseases, 74, 101574.

Deb, B., Uddin, A., & Chakraborty, S. (2018). miRNAs and ovarian cancer: An overview. Journal of Cellular Physiology, 233(5), 3846–3854.

Barman, A., Deb, B., & Chakraborty, S. (2020). A glance at genome editing with CRISPR Cas9 technology. Current Genetics, 66, 447–462.

Celine FABRET | Biology | Best Researcher Award

Published on by Innovation Technologist

Assist. Prof. Dr. Celine FABRET | Biology | Best Researcher Award

Lecturer at Paris-Saclay University, France

Dr. Céline Fabret is a Research Associate Professor at Paris-Saclay University, working at the Institut de Biologie Intégrative de la Cellule (I2BC). She holds a Ph.D. in Molecular Biology and Genetics from Université Aix-Marseille II and has extensive postdoctoral experience in both France and the United States. Her research focuses on translation termination, ribosome rescue mechanisms, prion biology, and gene regulation in bacteria and yeast. With a strong background in genetics and RNA biology, she has contributed to several international genome projects and has published in leading journals. Dr. Fabret is also an experienced educator and mentor, actively involved in training students and participating in academic governance.

Publication Profile 

Scopus

Educational Background 🎓

  • Ph.D. in Molecular Biology and Genetics, Université Aix-Marseille II, France (1996)

    • Doctoral research at CNRS Marseille, within the European-Japanese Bacillus subtilis genome project

  • Master’s in Molecular Biology, Université Aix-Marseille II, France

Professional Experience 💼

  • 2025–Present: Research Associate Professor, Paris-Saclay University, I2BC

  • 2011–Present: Faculty member, Paris-Saclay University (teaching microbiology, genetics, molecular biology, genomics)

  • 2001–2011: Lecturer, Sorbonne University (Pierre et Marie Curie Campus)

  • 1999–2001: Researcher in P. Noirot’s lab at INRA, Jouy-en-Josas – Genetic tools development and essential gene characterization

  • 1998–1999: Researcher in L. Jannière’s lab at INRA – High-frequency in vivo mutagenesis system in E. coli

  • 1996–1998: Postdoctoral Fellow, J.A. Hoch’s Lab, The Scripps Research Institute (La Jolla, USA) – Sporulation and two-component systems in Bacillus subtilis

  • 1991–1996: Doctoral researcher, CNRS Marseille – DNA sequencing and transcriptional analysis in B. subtilis

Research Interests 🔬

Dr. Fabret’s research bridges bacterial and eukaryotic translation, gene regulation, and RNA biology. Her focus includes:

  • Translation termination mechanisms in yeast and bacteria

  • Prion biology and its effect on stop codon recognition ([PSI+] phenotype)

  • Ribosome rescue and RNA quality control systems (RQC2, trans-translation)

  • Antibiotic response and translational reprogramming in Gram-negative bacteria

  • Functional genomics and essential gene analysis in Bacillus subtilis

  • Post-transcriptional modifications and their role in translational fidelity

She has supervised 2 PhD theses, 3 Master 2 (M2), and 16 Master 1 (M1) students, contributing to the training of the next generation of molecular biologists.

Awards and Honors🏆✨

  • Lead participant in multiple European research consortia on genome projects and enzyme engineering

  • Co-author of high-impact publications in Nature Cell Biology, Structure, Nucleic Acids Research, Molecular Microbiology

  • Elected member of the Consultative Commission of Biology Specialists and the Biology Department Council, Paris-Saclay University

  • Recognized for interdisciplinary collaboration with pharmaceutical companies (e.g., Aventis) and international institutions

Conclusion🌟

Dr. Céline Fabret has made sustained and meaningful contributions to molecular microbiology, translation biology, and bacterial physiology. Through a unique combination of genetic, biochemical, and functional genomics approaches, she has deepened our understanding of translation mechanisms and gene regulation across domains of life. As a researcher, educator, and mentor, she remains committed to advancing science and supporting young scientists in their careers.

Publications 📚

  1. 🧬 Fabret C, Giudice E, Chat S, Gillet R, Namy O (2025)
    RQC2 is a major player in peptide release from stalled ribosomes
    Structure, 31: S0969-2126(25)00105-4.

  2. 🦠 Fruchard L, Babosan A, Carvalho A, Lang M, Li B, Duchateau M, Giai Gianetto Q, Matondo M, Bonhomme F, Hatin I, Arbes H, Fabret C, et al. (2025)
    Aminoglycoside tolerance in Vibrio cholerae engages translational reprogramming
    (Accepted, journal not specified).

  3. 🧪 Fabret C, Namy O (2021)
    Translation efficiency of E. coli ribosomes with covalently linked subunits
    Nucleic Acids Research, 49(9): 5308–5318.

  4. 🔬 Malagnac*, Fabret* et al. (2013)
    A gene regulated by a -1 frameshift in Podospora anserina
    PLoS One, 8(9): e73772. (co-first authors)

  5. 🔎 Cosnier B, Kwapisz M, Hatin I, Namy O, Fabret C (2011)
    Translational readthrough of S. cerevisiae genes IMP3 and PDE2
    PLoS One, 6(4): e19500.

  6. 🧫 Desmolaize B, Fabret C, Graille M, van Tilbeurgh H, Brochier-Armanet C, Namy O (2011)
    23S rRNA modifications in Bacillus subtilis
    Nucleic Acids Research, 39(21): 9368–9375.

  7. 🧬 Fabret C, Malagnac F, Namy O (2011)
    tRNA-CAU modification enzyme and AUA codon recognition in Bacillus subtilis
    Molecular Microbiology, 80(4): 1062–1074.

  8. 💡 Blanchet S, Cornu D, Hatin I, Grosjean H, Bertin P, Namy O, Fabret C (2015)
    eRF1 interactions with stop codons and the ribosome
    Nucleic Acids Research, 43(6): 3298–3308.

  9. 🧠 Kabani M, Melki R, Fabret C (2011)
    Prion formation and the eRF3 protein in yeast
    Molecular Microbiology, 81(3): 640–658.

  10. 🔬 Tork S, Hatin I, Rousset JP, Fabret C (2004)
    5′ and 3′ context effects on stop codon recognition
    Nucleic Acids Research, 32(2): 415–421.